Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules
Hesham A. Abou‐Zied, Bahaa G. M. Youssif, Mamdouh F. A. Mohamed, et al.
Bioorganic Chemistry (2019) Vol. 89, pp. 102997-102997
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Chalcone Derivatives: Role in Anticancer Therapy
Yang Ouyang, Juanjuan Li, Xinyue Chen, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 894-894
Open Access | Times Cited: 239
Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
Pankaj Sharma, Chris LaRosa, Janet Antwi, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4213-4213
Open Access | Times Cited: 122
Anticancer Activity of Natural and Synthetic Chalcones
Teodora Constantinescu, Claudiu N. Lungu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11306-11306
Open Access | Times Cited: 114
Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives
Jagjit Singh Dhaliwal, Said Moshawih, Khang Wen Goh, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 7062-7062
Open Access | Times Cited: 70
Molecular targets and anticancer activity of quinoline–chalcone hybrids: literature review
Mamdouh F. A. Mohamed, Gamal El‐Din A. Abuo‐Rahma
RSC Advances (2020) Vol. 10, Iss. 52, pp. 31139-31155
Open Access | Times Cited: 117
Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure‐activity relationship
Feng Gao, Gang Huang, Jiaqi Xiao
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 2049-2084
Closed Access | Times Cited: 104
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104510-104510
Closed Access | Times Cited: 85
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity
Fatma A. Mohamed, Hesham A. M. Gomaa, Omnia M. Hendawy, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104960-104960
Closed Access | Times Cited: 59
Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer
Amr Ahmed WalyEldeen, Salwa Sabet, Haidan M. El-Shorbagy, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110297-110297
Closed Access | Times Cited: 58
Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities
Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105616-105616
Closed Access | Times Cited: 44
QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking
Hao Ding, Fei Xing, Lin Zou, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 10
Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAFV600E dual inhibitors
Lamya H. Al-Wahaibi, Ahmed M. Gouda, Ola F. Abou‐Ghadir, et al.
Bioorganic Chemistry (2020) Vol. 104, pp. 104260-104260
Closed Access | Times Cited: 62
Isatin-Schiff's base and chalcone hybrids as chemically apoptotic inducers and EGFR inhibitors; design, synthesis, anti-proliferative activities and in silico evaluation
Eman A. Fayed, Rogy R. Ezz Eldin, Ahmed B. M. Mehany, et al.
Journal of Molecular Structure (2021) Vol. 1234, pp. 130159-130159
Closed Access | Times Cited: 53
Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV
Heba A. Hofny, Mamdouh F. A. Mohamed, Hesham A. M. Gomaa, et al.
Bioorganic Chemistry (2021) Vol. 112, pp. 104920-104920
Closed Access | Times Cited: 52
Not Only Antimicrobial: Metronidazole Mitigates the Virulence of Proteus mirabilis Isolated from Macerated Diabetic Foot Ulcer
Ahdab N. Khayyat, Hisham A. Abbas, Mamdouh F. A. Mohamed, et al.
Applied Sciences (2021) Vol. 11, Iss. 15, pp. 6847-6847
Open Access | Times Cited: 45
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35
Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors
Mohamed Hisham, Heba A. Hassan, Hesham A. M. Gomaa, et al.
Journal of Molecular Structure (2022) Vol. 1254, pp. 132422-132422
Closed Access | Times Cited: 33
Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities
Asmaa Ahmed, Mamdouh F. A. Mohamed, Rasha M. Allam, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106171-106171
Closed Access | Times Cited: 28
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 27
Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells
Guanglong Zhang, Zhenhua Tang, Sili Fan, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 15
Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition
Mohammed M. Amin, Gamal El‐Din A. Abuo‐Rahma, Montaser Sh. A. Shaykoon, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106444-106444
Closed Access | Times Cited: 15
Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9104-9104
Open Access | Times Cited: 15
Design, synthesis, and apoptotic antiproliferative action of new benzimidazole/1,2,3-triazole hybrids as EGFR inhibitors
Abubakar Ahmed, Anber F. Mohammed, Zainab M. Almarhoon, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access
Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds
Farida Reymova, Belgin Sever, Edanur Topalan, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 270-270
Open Access
Click chemistry synthesis, biological evaluation and docking study of some novel 2′-hydroxychalcone-triazole hybrids as potent anti-inflammatory agents
Andrew N. Boshra, Hajjaj H.M. Abdu-Allah, Anber F. Mohammed, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103505-103505
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top